BLRX

BioLineRX
BLRX

31 hedge funds and large institutions have $2.42M invested in BioLineRX in 2024 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 4 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

0.01% more ownership

Funds ownership: 0% → 0.01% (+0.01%)

49% less call options, than puts

Call options by funds: $35K | Put options by funds: $69K

Holders
31
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$35K
Puts
$69K
Net Calls
Net Calls Change

Top Buyers

1
+$1.11M
2
+$462K
3
+$90.9K
4
AI
Atria Investments
North Carolina
+$59.7K
5
Cetera Investment Advisers
Cetera Investment Advisers
Illinois
+$30.6K

Top Sellers

1
-$127K
2
-$49.1K
3
-$38.8K
4
XT
XTX Topco
Cayman Islands
-$35.3K
5
LPL Financial
LPL Financial
California
-$10.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$850
27
$844
28
$801
29
$124
30
$114
31
–
32
–
33
–
34
–
1
2